Shares of Gilead Sciences (NASDAQ:GILD) rose after the company reported Q4 results.

Quarterly Results

Earnings per share were up 68.46% year over year to $2.19, which beat the estimate of $2.15.

Revenue of $7,421,000,000 up by 26.23% from the same period last year, which beat the estimate of $7,330,000,000.

Looking Ahead

Gilead Sees FY21 Adj. EPS $6.75-$7.45 vs $6.85 Estimate, Product Sales Including Veklury $23.7B-$25.1B

Details Of The Call

Date: Feb 04, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/u4wtgj6u

Price Action

Company's 52-week high was at $85.97

Company's 52-week low was at $56.56

Price action over last quarter: Up 12.25%

Company Profile